{"classes":[{"categories":[{"measurements":[{"groupId":"OG001","spread":"54.6","value":"2.51"},{"groupId":"OG002","spread":"68.4","value":"2.08"},{"groupId":"OG003","spread":"109.0","value":"2.02"},{"groupId":"OG004","spread":"33.6","value":"2.42"},{"groupId":"OG005","spread":"77.8","value":"2.56"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.56"},{"groupId":"OG001","spread":"74.2","value":"1.80"},{"groupId":"OG002","spread":"0.0","value":"2.01"},{"groupId":"OG003","spread":"23.1","value":"2.26"},{"groupId":"OG004","spread":"0.0","value":"2.09"},{"groupId":"OG005","spread":"28.2","value":"2.36"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"Steady State"}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 300 mg for 21 consecutive days, followed by 7 days off.","id":"OG000","title":"COB 80 mg + GDC 300 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 20 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG001","title":"COB 20 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 40 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG002","title":"COB 40 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG003","title":"COB 80 mg + GDC 200 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 400 mg for 21 consecutive days, followed by 7 days off.","id":"OG004","title":"COB 80 mg + GDC 400 mg"},{"description":"Concurrent or intermittent dosing of cobimetinib 100 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off.","id":"OG005","title":"COB 100 mg + GDC 200 mg"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Data are reported for evaluable participants.","reportingStatus":"POSTED","timeFrame":"Up to Day 22","title":"Maximum Serum Concentration (Cmax) for GDC-0994","type":"SECONDARY","unitOfMeasure":"micromoles"}